Profit

Buy Aurobindo pharma, Divis Lab, Alembic pharma: IndiaNivesh

PUBLISHED ON: June 7, 2012 | Duration: 35 min, 13 sec

facebooktwitteremailkoo
loading..
Daljeet Kohli, Head- Research at IndiaNivesh Securities, Jigar Lodaya, AVP at Sharekhan, Paras Adenwala, Investment Advisor and Phani Sekhar, Fund Manager PMS at Angel Broking discuss the stock markets. Daljeet Kohli advises investors to buy Alembic pharma with target of Rs 79, Aurobindo pharma with target of Rs 150 and Divis lab stocks with a target of Rs 1032 per share.
ALSO WATCH
Share Market News Today: भारत के शेयर बाज़ारों में रिकॉर्ड ऊंचाई, सेंसेक्स 75,000 और निफ्टी 22,700 के पार

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com